BCG Revaccination and Leprosy Protection in Brazil
Author Information
Author(s): Cunha Sérgio S., Alexander Neal, Barreto Mauricio L., Pereira Emilia S., Dourado Inês, de Fátima Maroja Maria, Ichihara Yury, Brito Silvana, Pereira Susan, Rodrigues Laura C.
Primary Institution: Instituto de Saúde Coletiva, Universidade Federal da Bahia
Hypothesis
BCG revaccination would cause a 50% reduction in leprosy incidence.
Conclusion
The study found no evidence that a second dose of BCG vaccination protects schoolchildren against leprosy.
Supporting Evidence
- The incidence rate ratio of leprosy in the intervention over the control arm was 0.99.
- Results showed no significant difference in leprosy cases between vaccinated and unvaccinated children.
- Follow-up lasted for 6 years and 8 months, involving nearly 100,000 children.
Takeaway
Giving kids a second shot of the BCG vaccine didn't help protect them from leprosy, just like the first shot.
Methodology
A cluster randomised community trial with 6 years and 8 months of follow-up involving schoolchildren aged 7-14 years.
Potential Biases
Potential bias due to the lack of blinding in diagnosis and the possibility of misdiagnosis.
Limitations
The study may have been affected by imbalances in baseline characteristics and the lack of blinding in diagnosis.
Participant Demographics
Schoolchildren aged 7-14 years, with a total of 99,770 participants.
Statistical Information
Confidence Interval
0.68 to 1.45
Statistical Significance
p>0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website